Table 1 Redox-dependent enzymatic activities of SARS-CoV-2 Mpro wild-type and variants

From: Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design

Mpro Variants

Reduced a Relative activity (%)

Oxidized b Relative activity (%)

Reactivation (after 200s) c

   

Relative activity (%)

Change (%)

Wild-type

100.0 ± 2.6d

30.5 ± 1.0

34.0 ± 1.0

+3.5%

   

Fully reversible overnighte

 

Cys-Ser variants

  C16S

75.3 ± 1.1

25.4 ± 0.1

27.1 ± 0.2

+1.7%

  C22S

84.4 ± 1.2

26.3 ± 0.2

31.2 ± 0.8

+4.9%

  C38S

92.1 ± 0.5

31.8 ± 0.3

36.4 ± 0.4

+4.6%

  C44S

16.4 ± 0.1

7.3 ± 0.3

7.6 ± 0.4

+0.3%

  C85S

71.2 ± 1.7

26.4 ± 0.8

29.5 ± 0.1

+3.1%

  C117S

41.9 ± 0.6

16.7 ± 0.1

14.2 ± 1.1

–2.5%

   

irreversible overnighte

 

  C128S

74.3 ± 0.6

22.5 ± 0.6

28.4 ± 1.1

+5.9%

  C145S

n. a.f

n. a.

n. a.

 

  C156S

77.5 ± 1.8

28.7 ± 0.7

35.0 ± 0.9

+6.3%

  C160S

92.7 ± 3.0

28.2 ± 0.5

30.1 ± 0.1

+1.9%

  C265S

85.1 ± 2.3

30.7 ± 0.4

34.4 ± 1.9

+3.7%

  C300S

92.7 ± 0.3

32.1 ± 0.4

35.9 ± 2.0

+3.8%

Additional SONOS variants

  C44A

29.4 ± 0.4

12.4 ± 0.5

11.1 ± 0.4

–1.3

  C22S_C44S

10.4 ± 0.4

4.0 ± 0.0

2.3 ± 0.2

–1.7

  K61A

55.2 ± 2.0

20.2 ± 2.4

18.7 ± 2.1

–1.5

  K61A_C22S

42.4 ± 1.9

16.6 ± 2.2

17.2 ± 0.7

+0.6

  K61A_C44S

10.2 ± 0.3

3.2 ± 0.0

3.5 ± 0.1

+0.3

  K61A_C22S_C44S

7.0 ± 1.4

3.0 ± 0.1

2.0 ± 0.3

–1.0

   

Partially reversible overnighte

 

 Y54F

19.4 ± 0.0

7.1 ± 1.8

8.2 ± 0.5

+1.1

  1. ain presence of 1 mM DTT.
  2. bafter oxidation with 1 mM H2O2 for 2 h on ice.
  3. cre-activation was initiated by addition of 20 mM DTT to the oxidized enzyme and kinetically analyzed 200 s after reduction.
  4. d100% activity refers to the activity of wild-type Mpro under reducing conditions.
  5. esee Supplementary Fig. 5 (wild-type), Supplementary Fig. 11 (variant C117S) and Supplementary Fig. 12 (variant K61A_C22S_C44S).
  6. fno measurable activity.
  7. Experimental details are provided in the Supplementary Methods.